Spending on u.s. medicines rose 12% in 2021 due to covid-19 vaccines and therapies, says iqvia institute for human data science

Research triangle park, n.c.--(business wire)--spending on medicines in the united states, at estimated net manufacturer prices, reached $407 billion in 2021, up 12% over 2020, as covid-19 vaccines and therapeutics became widely available and added $29 billion in related spending. that's according to a new u.s. medicines trends 2022 report, released today by the iqvia institute for human data science. in the same year, the non-covid medicines market grew more slowly, at 5%, from the growing imp
IQV Ratings Summary
IQV Quant Ranking